We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 26 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. 関東化学株式会社 Tokyo//Chemical バイオケミカル部
  3. null/null
  4. 4 キャタレント・ジャパン Tokyo//Manufacturing and processing contract
  5. 5 カツマタ Shizuoka//Medical and Welfare 医薬品製造販売部
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Aug 13, 2025～Sep 09, 2025
This ranking is based on the number of page views on our site.

  1. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  2. Development of various types of medium-sized molecule (nucleic acid, peptide) pharmaceuticals (processes, analytical methods, etc.)
  3. Global Procurement of Reference Drugs <From Drug Procurement to Problem Solving> キャタレント・ジャパン
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 Pharmaceutical CDMO services 大塚化学

medicine Product List

151～165 item / All 516 items

Displayed results
K9 Lab Inc. Company Profile

K9 Lab Inc. Company Profile

We support veterinary medicine by providing animal genetic testing technology and lymphocyte culture techniques.

Our company supports veterinary medicine by providing advanced genetic testing technology to assist in the diagnosis of cancers and infectious diseases, offering lymphocyte culture techniques used in cancer immunotherapy, and developing new functional foods that can be shared between pet owners and their pets, ensuring companion animals receive appropriate examinations and treatments. Currently, we are accepting tests from animal hospitals nationwide. Furthermore, we are developing technology to apply activated lymphocyte culture techniques to the health management of livestock (with domestic and foreign patents obtained) and have begun the development of artificial red blood cells for animals, aiming for early practical application. 【Business Activities】 ■ Contracting, research, development, and technical guidance for animal clinical testing ■ Research, development, manufacturing, and sales of veterinary diagnostic drugs ■ Research, development, manufacturing, import, and sales of veterinary pharmaceuticals, reagents, and medical instruments and tools ■ Contracting and technical guidance for cell culture, preservation, and management ■ Research commissioning and technical guidance related to animal medicine ■ Other related services *For more details, please refer to the PDF materials or feel free to contact us.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmatech Co., Ltd. "Company Profile"

Pharmatech Co., Ltd. "Company Profile"

Contract manufacturing of raw materials and intermediates is handled by Pharmatech Co., Ltd.

Pharmatech Co., Ltd. is a company located in Chuo Ward, Tokyo, engaged in the sales of pharmaceutical raw materials and intermediates. With a customer-oriented approach as our foundation, we aim to provide high-quality materials and services not only in Japan but also around the world. We consider it our significant mission to contribute to society through the sale of various raw materials related to pharmaceuticals, pharmaceutical intermediates, health foods, cosmetics, biochemical products, clinical testing reagents, industrial chemicals, and more. 【Business Activities】 ■ Export and sales of pharmaceutical raw materials ■ Sales of pharmaceutical intermediates, chemical products, toxic substances, reagents, and clinical testing reagents ■ Wholesale sales of pharmaceutical raw materials ■ Import and export, and domestic sales of food, food additives, and health foods ■ Sales of traditional Chinese medicine and plant extracts *For more details, please refer to our catalog. Feel free to contact us with any inquiries.

  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
For various titrations! The titration "indicator" specified in JIS K8001.

For various titrations! The titration "indicator" specified in JIS K8001.

【Extensive Selection】We offer indicators for neutralization titration, precipitation titration, redox titration, complexometric titration, etc., as specified in JIS K 8001!

"Indicators" are reagents used in titration. We offer indicators for neutralization titration, precipitation titration, redox titration, complexometric titration, etc., as specified in JIS K 8001. 【Product Lineup】 ◇ Iron(III) ammonium sulfate solution ◇ Bromocresol green solution ◇ Bromocresol purple solution ◇ Bromophenol blue solution ◇ Cresol red solution ◇ Cresol red solution ◇ Methyl red solution ◇ 4-Nitrophenol solution ◇ Phenolphthalein solution ◇ Phenol red solution ◇ Thymol blue solution ◇ Uranine solution 　　　　　　…etc For more details, please download the catalog or feel free to contact us. Additionally, we handle reagents such as volumetric analysis titration solutions compliant with ISO/IEC 17025. Please refer to the catalog for more information.

  • RAA-17滴定液調製液.png
  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
BioBridge Corporation Business Introduction

BioBridge Corporation Business Introduction

Due to our long-standing track record, we have been entrusted with numerous agency operations.

BioBridge Co., Ltd. has been expanding its transactions with high-quality pharmaceutical raw material manufacturers and contract laboratories, primarily in Europe and including Asia, since its establishment. We are also engaged in transactions with domestic pharmaceutical and chemical companies. We handle a wide range of products, from antibiotic raw material intermediates to generic active pharmaceutical ingredients, and radioactive isotopes (14C, 3H). 【Business Activities】 ■ Sales of pharmaceutical raw materials, radioactive isotopes, and chemicals ■ Liaison office and agency services for overseas pharmaceutical companies, testing and inspection organizations, and contract manufacturing companies ■ Application services for registration of pharmaceutical raw materials, among others *For more details, please download the PDF or feel free to contact us.

  • Pharmaceutical Intermediates

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Contract synthesis of small quantities of high-quality active pharmaceutical ingredients.

Contract synthesis of small quantities of high-quality active pharmaceutical ingredients.

Supports the manufacturing of investigational drug active ingredients and pharmaceutical active ingredients ranging from hundreds of grams to several kilograms!

At Kyu Chemical, we also handle the manufacturing of active pharmaceutical ingredients (APIs) for clinical trial drugs and pharmaceutical products on a gram scale. We conduct process improvements and data management with the premise of commercialization from the development stage, supporting everything from process development to market launch. Production activities are carried out under a management system compliant with ICH and PIC/S guidelines, and we are also capable of synthesizing compounds for drug discovery and related substances. If you have active pharmaceutical ingredients that are too small in quantity and have been rejected by overseas manufacturers, please contact us. 【Features】 ■ Manufacturing of highly pharmacologically active pharmaceutical ingredients (HPAPI) ■ Manufacturing of APIs for clinical trial drugs ■ Manufacturing of small quantities of APIs *For more details, please refer to the related links or feel free to contact us.

  • Other contract services
  • Other services
  • Chemicals

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
All-purpose test reagent

All-purpose test reagent

Measures from low range "LR" 0.02 to 2 mg/L and high range "HR" 0.2 to 30 mg/L.

We offer a total phosphorus test reagent based on the measurement principle of spectrophotometry (molybdenum blue method). The measurement ranges are low range "LR" 0.02 to 2 mg/L and high range "HR" 0.2 to 30 mg/L, with a processing time of 30 minutes at 125°C. *For more details, please download the PDF or contact us.

  • Testing Equipment and Devices

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Pharmaceutical Active Ingredient Division (Pharmaceutical Research Headquarters) Business and Technology

Pharmaceutical Active Ingredient Division (Pharmaceutical Research Headquarters) Business and Technology

Process optimization is possible! We propose a balanced active pharmaceutical ingredient development plan that considers speed, cost-effectiveness, and quality.

We would like to introduce our pharmaceutical active ingredient division (Pharmaceutical Research Headquarters) and its business and technology. We flexibly utilize a network of reliable partner contract manufacturers to build and propose an optimal active ingredient manufacturing supply chain tailored to specific purposes. With world-class pharmaceutical development technology and assured quality, we provide "the development of active ingredient manufacturing methods from 'zero' that meet global application requirements" and "a seamless and consistent active ingredient manufacturing process and quality design from preclinical stages to obtaining marketing approval." 【Features】 ■ Development of active ingredient manufacturing methods from 'zero' based on technology and know-how cultivated over many years at major domestic pharmaceutical companies. ■ Establishment of active ingredient manufacturing methods and quality design according to development stages and applications. ■ Flexible response to active ingredient manufacturing requests. ■ Accurate support for application processes (clinical trials and commercial use). *For more details, please refer to the PDF materials or feel free to contact us.

  • Other contract services
  • Technology Development

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Technology and Achievements Introduction] Absorption Improvement Technology (Nanosized Formulation)

[Technology and Achievements Introduction] Absorption Improvement Technology (Nanosized Formulation)

Introducing the correlation diagram of particle size and surface area! It is applied to investigational drugs targeting compounds in the development stage.

We would like to introduce Spela Pharma's "Absorption Improvement Technology." By using nano-sized active pharmaceutical ingredients, we enhance bioavailability. We have successfully developed formulations using this technology and are applying it to investigational drugs targeting compounds in the development stage. On our website, we provide a correlation chart of particle size and surface area, as well as graphs showing plasma concentration in dogs for nano-particles and jet-milled active pharmaceutical ingredients, so please check the related links below. [Features] ■ Improved bioavailability through nano-sized active pharmaceutical ingredients ■ Successful development of formulations using this technology ■ Application to investigational drugs targeting compounds in the development stage *For more details, please refer to the PDF materials or feel free to contact us.

  • Other contract services
  • Technology Development

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Thank You] CPhI Japan 2022

[Thank You] CPhI Japan 2022

Thank you for attending CPhI Japan 2022 (International Pharmaceutical Development Exhibition)!

Sperafarma exhibited at CPhI Japan 2022 (International Pharmaceutical Development Exhibition, April 20-22, Tokyo Big Sight) and welcomed many customers to our booth. As a CDMO capable of providing a wide range of services from early-stage R&D to the manufacturing of clinical trial drugs, commercial manufacturing, and raw material procurement, we will accelerate our support for pharmaceutical development. We would like to express our gratitude to everyone who provided us with opportunities for exchanging opinions and sharing information. 【Overview of Presentations at the Booth】 ■ Screening technologies required in active pharmaceutical ingredient research - catalyst selection, crystallization - ■ Mutagenic impurities in pharmaceuticals (active pharmaceutical ingredients) - development of testing methods and analysis examples - *For more details, please refer to the PDF materials or feel free to contact us.

  • Fine chemicals (compounds, derivatives, catalysts, etc.)
  • Other Testing Contract
  • Other analytical and testing equipment

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)

[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)

Development of testing methods and analysis examples! Established over 300 analytical methods that can guarantee PMI residues below 10 ppm!

At "CPhI Japan 2022," we held a presentation in our booth regarding ICH M7 compliance from the Development and Analytical Research Headquarters. We introduced the day's content, including "About ICH M7," "For the Development of Trace Analysis Methods," and "Examples of Method Validation." Please take a moment to read it. [Contents] ■ About ICH M7 ■ For the Development of Trace Analysis Methods ■ Examples of Method Validation ■ Conclusion *For more details, please refer to the related links page or feel free to contact us.

  • Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antimicrobial Treatment

[Research Material] Global Market for Antimicrobial Treatment

Global Market for Antimicrobial Therapy: Penicillin, Cephalosporins, Quinolones, Aminoglycosides, Monobactams, Carbapenems, Macrolides, ...

This research report (Global Antibacterial Therapeutic Market) investigates and analyzes the current state of the global antibacterial therapeutic market and its outlook for the next five years. It includes information on the overview of the global antibacterial therapeutic market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the antibacterial therapeutic market include penicillin, cephalosporins, quinolones, aminoglycosides, monobactams, carbapenems, macrolides, and others, while the segments by application cover oral, topical, non-oral, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for antibacterial therapeutics. It also includes the market share of major companies in antibacterial therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Scleroderma Treatment Solutions

[Research Material] Global Market for Scleroderma Treatment Solutions

Global Market for Scleroderma Treatment Solutions: Immunotherapy, Antifibrotic Drugs, Others, Hospitals, Clinics, Others

This research report (Global Scleroderma Therapy Solutions Market) investigates and analyzes the current status and outlook for the global market for scleroderma treatment solutions over the next five years. It includes information on the overview of the global scleroderma treatment solutions market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include immunotherapy, anti-fibrotic drugs, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for scleroderma treatment solutions. It also includes the market share of major companies in the scleroderma treatment solutions sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Acute Heart Failure (AHF) Treatment Drugs

[Research Material] Global Market for Acute Heart Failure (AHF) Treatment Drugs

World Market for Acute Heart Failure (AHF) Treatment Drugs: Beta-blockers, Calcium Channel Blockers, Cardiac Glycosides, Diuretics, Morphine, Vasodilators/Nitrates ...

This research report (Global Acute Heart Failure (AHF) Therapeutics Market) investigates and analyzes the current status and outlook for the global market of acute heart failure (AHF) therapeutics over the next five years. It includes information on the overview of the global acute heart failure (AHF) therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include beta-blockers, calcium channel blockers, cardiac glycosides, diuretics, morphine, vasodilators/nitrates, and others, while the segments by application focus on hospitals, clinics, and home care. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for acute heart failure (AHF) therapeutics. It also includes the market share of major companies in the acute heart failure (AHF) therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Psoriatic Arthritis Treatments

[Research Material] Global Market for Psoriatic Arthritis Treatments

World Market for Psoriatic Arthritis Treatments: Non-Steroidal Anti-Inflammatory Drugs, Disease-Modifying Anti-Rheumatic Drugs, Biological Agents, Enzyme Inhibitors, Hospitals, Clinics, Laboratories

This research report (Global Psoriatic Arthritis Therapeutics Market) investigates and analyzes the current state and outlook for the global market for psoriatic arthritis therapeutics over the next five years. It includes information on the overview of the global psoriatic arthritis therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include non-steroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, biological agents, and enzyme inhibitors, while the segments by application focus on hospitals, clinics, and laboratories. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for psoriatic arthritis therapeutics. It also includes the market share of major companies in the psoriatic arthritis therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Sodium Lauryl Sulfate

[Research Material] The Global Market for Sodium Lauryl Sulfate

World Market for Sodium Lauryl Sulfate: Gastrointestinal and Metabolic Sodium Lauryl Sulfate, Constipation Treatment Sodium Lauryl Sulfate ...

This research report (Global Sodium Lauryl Sulfoacetate Market) investigates and analyzes the current status and outlook for the global sodium lauryl sulfoacetate market over the next five years. It includes information on the overview of the global sodium lauryl sulfoacetate market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include gastrointestinal and metabolic sodium lauryl sulfoacetate, constipation treatment sodium lauryl sulfoacetate, and enema sodium lauryl sulfoacetate. The segments by application focus on human health, emergency medical services, laboratories, animal toxicity, and metabolism/pharmacokinetics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of sodium lauryl sulfoacetate. It also includes the market share of major companies in sodium lauryl sulfoacetate, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.